End Stage Renal Disease Patient

#777110 Topic: End Stage Renal Disease Patient Number of sources: 5 Writing Style: APA Type of document: Case Study Academic Level:Master Number of Pages: 3 (Single Spaced) Category: Nursing VIP Support: N/A Language Style: English (U.S.) Order Instructions: Case Study and Plan of Care. For Patient with End Stage Renal Diseased What is the effect of spkt/v on the hospitalization rate of a patient who has active fistula or graft in-center hemodialysis with the primary cause of kidney failure of either diabetes or hypertension? P- Patient on hemodialysis age from 18 -100 3 X a week treatment with active fistula or graft With Diabetes or Hypertension as the primary cause of Kidney Failure. I – Patient with spkt/v of 1.61 and above hospitalization rate C- Patient with spkt/v of lower than1.39 not meeting the goal and patient with spkt/v of 1.4 – 1.6 hospitalization rate O- Patient with spkt/v of 1.61 or higher will have a lower hospitalization rate T – 3 months (February 01 –April 30, 2018) ?Apply Health Promotion and Disease Prevention, and demonstrate the ability to develop a holistic plan of care, incorporating Telehealth, defining assessment and intervention of specific population incorporating unique attributes of populations for health promotion, wellness preservation and maintenance of function across the health-illness continuum. Directions: Develop a case study and a plan of care, incorporating current mobile App technology: 1. Select a population. Define your population by gender, age, ethnicity, socioeconomic status, spiritual need, and healthcare need .Apply concepts learned in course to identify healthcare needs needs specific to the population and access to care 2. Describe how Telehealth could impact the delivery of care to this population. 3. Identify PICO specific to the population you chose in #1Define a plan of care. 4. Submit your assignment via the D2L Dropbox This project is to be a total of 3 pages, typed. 12 pt font, 1” margins, Times New Roman.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *